标题: Hisun Biomaterials Reports RMB 953 Million Revenue, with Printing Contributing About Half [打印本页] 作者: admin 时间: 2026-11-4 20:04 标题: Hisun Biomaterials Reports RMB 953 Million Revenue, with Printing Contributing About Half On November 3, 2026, Nanjixiong learned that Zhejiang Hisun Biomaterials (688203) had reported revenue of approximately RMB 953 million for the first three quarters, up 53.41% year on year. Net profit attributable to listed-company shareholders was approximately RMB 27.447 million, up 459.49%; net profit excluding non-recurring items approximately RMB 26.8466 million, up 623.95%; and net operating cash flow approximately RMB 220 million, up 504.60%. The company mainly attributed revenue growth to continued favorable demand for printing consumables.
Q3 revenue was approximately RMB 347 million, up 62.76%, with attributable net profit approximately RMB 6.5249 million, up 278.43%. The company specializes in PLA. Previous investor-relations disclosures put printing at approximately half of revenue, implying around RMB 480 million in printing revenue for the first three quarters. Existing PLA capacity is 125,000 tonnes. Subsidiary Haichuangda's first-phase 75,000-tonne-per-year line within a 150,000-tonne project entered operation in May 2026.
Nanjixiong's Observations
PLA is a principal desktop FDM material. These results confirm strong consumer-printing demand from the upstream raw-material perspective. The net-profit base remains small, but RMB 220 million operating cash flow, up more than fivefold year on year, shows real cash collection rather than merely accounting-based revenue growth.
AI-translated from an article by Kuaixiong on Nanjixiong, originally published on 2026-11-03. Text and images retain the original source attribution. Read the original Chinese article
欢迎光临 All Voice of China 3D Printing (https://panda3dp.com/)